ZNF263, a member of the Krüppel-like zinc finger protein family, exerts critical functions in gene regulation and chromatin organization. As a transcription factor, ZNF263 contains multiple C2H2-type zinc finger motifs enabling its binding to specific DNA sequences, thereby modulating gene expression. The primary role of ZNF263 involves transcriptional regulation, where it acts as either an activator or repressor depending on its context within the genome. Through its interactions with various transcriptional regulators and chromatin-modifying enzymes, ZNF263 contributes to fundamental biological processes, including cellular proliferation, differentiation, and development.
Inhibition of ZNF263 involves multifaceted mechanisms aimed at suppressing its transcriptional activity and DNA-binding ability. One potential avenue of inhibition is through interference with its post-translational modifications, such as phosphorylation or acetylation, which are crucial for modulating its stability and DNA-binding affinity. Additionally, inhibition may occur through disruption of protein-protein interactions between ZNF263 and its co-regulators or transcriptional partners, preventing the formation of functional regulatory complexes required for proper gene expression control. Furthermore, targeting upstream signaling pathways that regulate ZNF263 expression or activity could provide another strategy for inhibition. By elucidating the intricate mechanisms underlying ZNF263 inhibition, insights can be gained into its role in transcriptional regulation and its potential implications in pathological conditions where dysregulated gene expression occurs.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, potentially altering the epigenetic regulation of genes, including those bound by ZNF263. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Non-nucleoside DNA methyltransferase inhibitor, could alter the methylation pattern of ZNF263 target genes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, could affect chromatin structure and gene expression profiles involving ZNF263. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, could indirectly influence ZNF263's ability to regulate gene transcription. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Aldehyde dehydrogenase inhibitor, might indirectly alter cellular pathways that ZNF263 is involved in. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
NF-κB pathway inhibitor, potentially affecting gene expression patterns that ZNF263 influences. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, which could affect downstream gene expression regulated by ZNF263. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, potentially altering signaling pathways and gene expression relevant to ZNF263. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Inhibits various signaling pathways and could modulate the transcriptional activity of ZNF263. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator, might influence histone and DNA modifications affecting ZNF263's gene regulatory functions. | ||||||